COMMITMENTS AND CONTINGENCIES - Legal Proceedings and License Agreement (Details)		9 Months Ended
Sep. 26, 2017 shareholder	Oct. 31, 2017 USD ($)
License Agreement
Lawsuit filed by number of shareholders \| shareholder	2
Royalties paid \| $		$ 0
License Agreement \| Iogen, LLC.
License Agreement
Non Royalty license fee equal to a certain percentage of net profit associated with OTC product		30.00%
Non Royalty license fee equal to a certain percentage of net royalties received from any sub-licensee		30.00%
License Agreement \| Prescription Iodine Tablet \| Iogen, LLC.
License Agreement
Royalty fee percentage based on net sales over a specific time period of commercialization		3.00%
Royalty fee percentage based on net sales after a specific period of time		2.00%
Time period for determining initial royalty fee as a percent of net sales		24 months
License Agreement \| Other Products \| Iogen, LLC.
License Agreement
Royalty fee percentage based on net sales over a specific time period of commercialization		3.00%
Royalty fee percentage based on net sales from initial period until expiration of applicable patents		2.00%
Royalty fee percentage based on net sales after a specific period of time		1.00%
Time period for determining initial royalty fee as a percent of net sales		12 months

Represents the number of shareholders that filed a lawsuit.

No definition available.

Name:	bpmx_LossContingencyLawsuitFiledByNumberOfShareholders
Namespace Prefix:	bpmx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the non-royalty license fees equal to a certain percentage of net profit associated with direct commercialization of an OTC product.

+ References

No definition available.

+ Details

Name:	bpmx_NonRoyaltyLicenseFeeEqualToCertainPercentageOfNetProfit
Namespace Prefix:	bpmx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the non-royalty license fee equal to a certain percentage of net royalties received from any sub-licensee.

+ References

No definition available.

+ Details

Name:	bpmx_NonRoyaltyLicenseFeeEqualToCertainPercentageOfNetRoyaltiesReceivedFromSubLicensee
Namespace Prefix:	bpmx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Period of time for determining initial royalty fee as a percent of net sales.

+ References

No definition available.

+ Details

Name:	bpmx_RoyaltyFeeInitialPeriodOfTime
Namespace Prefix:	bpmx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the royalty fee percentage based on net sales over a specific time period of commercialization.

+ References

No definition available.

+ Details

Name:	bpmx_RoyaltyFeePercentOfNetSales
Namespace Prefix:	bpmx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the royalty fee percentage based on net sales from initial period until expiration of applicable patents.

+ References

No definition available.

+ Details

Name:	bpmx_RoyaltyFeePercentOfNetSalesUntilExpiration
Namespace Prefix:	bpmx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the royalty fee percentage based on net sales after a specific period of time.

+ References

No definition available.

+ Details

Name:	bpmx_RoyaltyFeePercentageOfNetSalesAfterSpecificTimePeriod
Namespace Prefix:	bpmx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

+ Details

Name:	us-gaap_RoyaltyExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=bpmx_LicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CounterpartyNameAxis=bpmx_IogenLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ProductOrServiceAxis=bpmx_PrescriptionIodineTabletMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ProductOrServiceAxis=bpmx_OtherProductsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: